OBJECTIVE: To develop a reliable and valid child and parent self-report instrument to screen children with anxiety disorders. METHOD: An 85-item questionnaire was administered to 341 outpatient children and adolescents and 300 parents. Utilizing item analyses and factor analyses, the original scale was reduced to 38 items. A subsample of children (n = 88) and parents (n = 86) was retested an average of 5 weeks (4 days to 15 weeks after the initial screening. RESULTS: The child and parent Screen for Child Anxiety Related Emotional Disorders (SCARED) both yielded five factors: somatic/panic, general anxiety, separation anxiety, social phobia For the total score and each of the five factors, both the child and parent SCARED demonstrated good internal consistency (alpha = .74 to .93), test-retest reliability (intraclass correlation coefficients = .70 to .90), discriminative validity (both between anxiety and other disorders and within anxiety disorders), and moderate parent-child agreement (r = .20 to .47, p < .001, all correlations). CONCLUSIONS: The SCARED shows promise as a screening instrument for anxiety disorders. Future studies using the SCARED in community samples are indicated.
OBJECTIVE: To develop a reliable and valid child and parent self-report instrument to screen children with anxiety disorders. METHOD: An 85-item questionnaire was administered to 341 outpatientchildren and adolescents and 300 parents. Utilizing item analyses and factor analyses, the original scale was reduced to 38 items. A subsample of children (n = 88) and parents (n = 86) was retested an average of 5 weeks (4 days to 15 weeks after the initial screening. RESULTS: The child and parent Screen for ChildAnxiety Related Emotional Disorders (SCARED) both yielded five factors: somatic/panic, general anxiety, separation anxiety, social phobia For the total score and each of the five factors, both the child and parent SCARED demonstrated good internal consistency (alpha = .74 to .93), test-retest reliability (intraclass correlation coefficients = .70 to .90), discriminative validity (both between anxiety and other disorders and within anxiety disorders), and moderate parent-child agreement (r = .20 to .47, p < .001, all correlations). CONCLUSIONS: The SCARED shows promise as a screening instrument for anxiety disorders. Future studies using the SCARED in community samples are indicated.
Authors: Cecile D Ladouceur; John S Slifka; Ronald E Dahl; Boris Birmaher; David A Axelson; Neal D Ryan Journal: Dev Cogn Neurosci Date: 2012-02-08 Impact factor: 6.464
Authors: Genna Bebko; Michele A Bertocci; Jay C Fournier; Amanda K Hinze; Lisa Bonar; Jorge R C Almeida; Susan B Perlman; Amelia Versace; Claudiu Schirda; Michael Travis; Mary Kay Gill; Christine Demeter; Vaibhav A Diwadkar; Gary Ciuffetelli; Eric Rodriguez; Thomas Olino; Erika Forbes; Jeffrey L Sunshine; Scott K Holland; Robert A Kowatch; Boris Birmaher; David Axelson; Sarah M Horwitz; L Eugene Arnold; Mary A Fristad; Eric A Youngstrom; Robert L Findling; Mary L Phillips Journal: JAMA Psychiatry Date: 2014-01 Impact factor: 21.596
Authors: Nicholas F Wymbs; Catherine Orr; Matthew D Albaugh; Robert R Althoff; Kerry O'Loughlin; Hannah Holbrook; Hugh Garavan; Janitza L Montalvo-Ortiz; Stewart Mostofsky; James Hudziak; Joan Kaufman Journal: Child Abuse Negl Date: 2020-02-14
Authors: Michael B Himle; Matthew R Capriotti; Loran P Hayes; Krishnapriya Ramanujam; Lawrence Scahill; Denis G Sukhodolsky; Sabine Wilhelm; Thilo Deckersbach; Alan L Peterson; Matt W Specht; John T Walkup; Susanna Chang; John Piacentini Journal: Behav Modif Date: 2014-04-28